Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary
- 16 May 2014
- journal article
- Published by Springer Science and Business Media LLC in The European Journal of Health Economics
- Vol. 15 (1), 111-119
- https://doi.org/10.1007/s10198-014-0600-x
Abstract
There is a growing interest in policy making for using utility measures and identifying algorithms to convert disease-specific measures into utilities. To analyse the relationship between EQ-5D, Dermatology Life Quality Index (DLQI) and Psoriasis Area and Severity Index (PASI) in psoriasis. To transform DLQI scores, and key clinical, demographic and health service utilisation variables into utilities. A cross-sectional questionnaire survey of 200 consecutive adult patients with moderate to severe psoriasis was carried out in two Hungarian university clinics. The relationship between the outcome measures were analysed with correlations and with the known-groups method. Bivariate and multivariate regression algorithms on EQ-5D scores were formulated. The mean age of respondents was 51 years (SD = 12.9), 68.5 % were male, and 51.5 % received biological therapy. Median EQ-5D, DLQI, and PASI scores were 0.73, 3.0, and 3.45, respectively. EQ-5D showed a moderate correlation with the DLQI and with the PASI (r s = −0.48 and −0.43, p r s = 0.81, p EQ-5D. Presence of psoriasis on the neck and/or décolletage was associated with the greatest health related quality of life (HRQOL) impairment. Ten variables were incorporated in a multivariate algorithm that accounted for 48.8 % of EQ-5D variance (ANOVA p This study provided the first evidence that patients with visible psoriatic lesions have significantly worse HRQOL compared to those with non-visible lesions, measured not only with DLQI but also with EQ-5D. In addition to demographic and clinical variables, our model included health service utilisation variables related to psoriasis, and explained higher proportion of EQ-5D variance than any previous findings in the literature.Keywords
This publication has 32 references indexed in Scilit:
- Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapiesJournal of the European Academy of Dermatology and Venereology, 2013
- Review of studies mapping from quality of life or clinical measures to EQ-5D: an online databaseHealth and Quality of Life Outcomes, 2013
- Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational studyBMC Medicine, 2012
- Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaireHealth and Quality of Life Outcomes, 2012
- Living with Psoriasis: Prevalence of Shame, Anger, Worry, and Problems in Daily Activities and Social LifeActa Dermato Venereologica, 2012
- What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literatureJournal of the European Academy of Dermatology and Venereology, 2010
- Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional surveyScandinavian Journal of Rheumatology, 2010
- A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measuresThe European Journal of Health Economics, 2009
- The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical resultsBritish Journal of Dermatology, 2008
- A power primer.Psychological Bulletin, 1992